H. Oshikawa

Risk of serious infection, malignancy, or death in Japanese rheumatoid arthritis patients treated with a combination of abatacept and tacrolimus: a retrospective cohort study

T. Matsui, S. Tohma, K. Matsui, 2020, Clinical Rheumatology.

An observational study of tocilizumab and TNF-α inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety

G. Deshpande, Y. Tokuda, M. Kishimoto, 2011, Rheumatology.

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.

D. T. Gray, Janet A. Blood, I. Bruce, 2020, Rheumatology.

Evaluation of the effect of foot disease activity on Boolean remission in Japanese patients with rheumatoid arthritis: A cross‐sectional study

A. Shiraishi, S. Tohma, N. Hagino, 2018, Musculoskeletal care.

Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behçet’s syndrome for patients in the US and Japan: data from a large, three-center cohort study

Y. Tokuda, M. Okada, M. Kishimoto, 2013, Modern rheumatology.

Dermatomyositis-related interstitial lung disease mimicking COVID-19 pneumonia

Y. Imamura, K. Tokunaga, H. Oshikawa, 2021, Cleveland Clinic Journal of Medicine.

Generalised edema with human parvovirus B19 infection

H. Oshikawa, Satoshi Hayano, 2021, BMJ Case Reports.

A graphic demonstration that the Disease Activity Score in 28 joints using the erythrocyte sedimentation rate is overly sensitive when erythrocyte sedimentation rates are low: Comment on the article by Smolen and Aletaha.

G. Deshpande, M. Kishimoto, Tatsuo Kobayashi, 2011, Arthritis and rheumatism.